Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications

被引:127
作者
Nelson, Bryce J. B. [1 ]
Andersson, Jan D. [1 ,2 ]
Wuest, Frank [1 ]
机构
[1] Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada
[2] Alberta Hlth Serv, Edmonton Radiopharmaceut Ctr, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada
关键词
targeted alpha therapy; alpha particle therapy; targeted radionuclide therapy; theranostics; actinium-225; bismuth-213; astatine-211; radium-223; thorium-227; terbium-149;
D O I
10.3390/pharmaceutics13010049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review outlines the accomplishments and potential developments of targeted alpha (alpha) particle therapy (TAT). It discusses the therapeutic advantages of the short and highly ionizing path of alpha-particle emissions; the ability of TAT to complement and provide superior efficacy over existing forms of radiotherapy; the physical decay properties and radiochemistry of common alpha-emitters, including Ac-225, Bi-213, Ra-224, Pb-212, Th-227, Ra-223, At-211, and Tb-149; the production techniques and proper handling of alpha-emitters in a radiopharmacy; recent preclinical developments; ongoing and completed clinical trials; and an outlook on the future of TAT.
引用
收藏
页码:1 / 28
页数:26
相关论文
共 118 条
[21]   Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy [J].
Cedrowska, Edyta ;
Pruszynski, Marek ;
Majkowska-Pilip, Agnieszka ;
Meczynska-Wielgosz, Sylwia ;
Bruchertseifer, Frank ;
Morgenstern, Alfred ;
Bilewicz, Aleksander .
JOURNAL OF NANOPARTICLE RESEARCH, 2018, 20 (03)
[22]   In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy [J].
Chan, Ho Sze ;
de Blois, Erik ;
Morgenstern, Alfred ;
Bruchertseifer, Frank ;
de Jong, Marion ;
Breeman, Wouter ;
Konijnenberg, Mark .
PLOS ONE, 2017, 12 (07)
[23]   Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine [J].
Chan, Ho Sze ;
Konijnenberg, Mark W. ;
Daniels, Tamara ;
Nysus, Monique ;
Makvandi, Mehran ;
de Blois, Erik ;
Breeman, Wouter A. ;
Atcher, Robert W. ;
de Jong, Marion ;
Norenberg, Jeffrey P. .
EJNMMI RESEARCH, 2016, 6
[24]   Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation [J].
Choi, Jaeyeon ;
Vaidyanathan, Ganesan ;
Koumarianou, Eftychia ;
Kang, Choong Mo ;
Zalutsky, Michael R. .
NUCLEAR MEDICINE AND BIOLOGY, 2018, 56 :10-20
[25]  
Cooks T, 2012, ANTICANCER RES, V32, P5315
[26]   Alpha Particle Detection Using Alpha-Induced Air Radioluminescence: A Review and Future Prospects for Preliminary Radiological Characterisation for Nuclear Facilities Decommissioning [J].
Crompton, Anita J. ;
Gamage, Kelum A. A. ;
Jenkins, Alex ;
Taylor, Charles James .
SENSORS, 2018, 18 (04)
[27]   Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity [J].
Current, Kyle ;
Meyer, Catherine ;
Magyar, Clara E. ;
Mona, Christine E. ;
Almajano, Joel ;
Slavik, Roger ;
Stuparu, Andreea D. ;
Cheng, Chloe ;
Dawson, David W. ;
Radu, Caius G. ;
Czernin, Johannes ;
Lueckerath, Katharina .
CLINICAL CANCER RESEARCH, 2020, 26 (12) :2946-2955
[28]   Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab [J].
Dahle, Jostein ;
Jonasdottir, Thora J. ;
Heyerdahl, Helen ;
Nesland, Jahn M. ;
Borrebaek, Jorgen ;
Hjelmerud, Anne Kristine ;
Larsen, Roy H. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :93-102
[29]   177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors [J].
Das, Satya ;
Al-Toubah, Taymeyah ;
El-Haddad, Ghassan ;
Strosberg, Jonathan .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) :1023-1031
[30]   Improved in vivo stability of actinium-225 macrocyclic complexes [J].
Deal, KA ;
Davis, IA ;
Mirzadeh, S ;
Kennel, SJ ;
Brechbiel, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2988-2992